Related Experiment Video
Updated: Jan 26, 2026

Examining Changes in HRV and Emotion Following Artmaking with Three Different Art Materials
Published on: January 11, 2020
SOHO State of the Art Updates and Next Questions: Myelofibrosis
Kristen Pettit1, Srdan Verstovsek2, Moshe Talpaz1
1University of Michigan Rogel Cancer Center, Ann Arbor, MI.
Abstract:
The discovery of a mutation in the Janus Kinase 2 gene in 2005 spurred significant progress in the field of myeloproliferative neoplasms. A comprehensive description of genomic factors at play in the malignant clone in myeloproliferative neoplasms, particularly myelofibrosis (MF), have recently led to more precise, personalized prognostic tools. Despite this, understanding of the disease pathogenesis remains relatively limited. We continue to lack a detailed description of the interaction between the hematopoietic stem cell clone, abnormal bone marrow niche cells, and circulating signaling molecules and an understanding of how they cooperate to promote cell proliferation, fibrogenesis, and extramedullary hematopoiesis. Despite our knowledge gaps, recent research in MF has led to promising clinical translation. In this article, we summarize recent insights into MF pathophysiology, progress in the development of novel therapeutics, and opportunities for further advancement of the field.
Insights
Recent insights into myelofibrosis (MF) pathophysiology have improved prognostic tools. Further research is needed to fully understand disease mechanisms and develop novel therapeutics for this myeloproliferative neoplasm.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- The discovery of Janus Kinase 2 (JAK2) mutations in 2005 advanced myeloproliferative neoplasms (MPNs) research.
- Genomic insights into myelofibrosis (MF) have enabled personalized prognostic tools.
- Significant knowledge gaps persist regarding MF pathogenesis, including stem cell interactions and signaling pathways.
Purpose of the Study:
- To summarize recent advancements in understanding MF pathophysiology.
- To review the progress in developing novel therapeutics for MF.
- To identify future research directions in the field of MF.
Main Methods:
- Literature review of recent studies on MF pathophysiology.
- Analysis of current therapeutic strategies and clinical trials for MF.
- Discussion of knowledge gaps and future research opportunities.
Main Results:
- Recent research has provided a more comprehensive understanding of genomic factors in MF.
- Novel prognostic tools have been developed based on these genomic insights.
- Promising clinical translations are emerging despite incomplete understanding of disease mechanisms.
Conclusions:
- Continued research into MF pathogenesis is crucial for developing effective treatments.
- Understanding the interplay between stem cells, the bone marrow niche, and signaling molecules is key.
- Further advancements in MF therapeutics are anticipated through ongoing research and clinical translation.
More Related Videos
Related Concept Videos
Schemas
The Sense of Self: Reflected Self-Appraisal and Social Comparison
The Scientific Method
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
Archival Research
Surveys

